| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.44 | 6e-12 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.42 | 1e-11 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.24 | 5e-09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.34 | 3e-08 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.25 | 7e-08 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-07 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.32 | 7e-07 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-06 |